Randomised controlled trial of rituximab in active ulcerative colitis

Trial Profile

Randomised controlled trial of rituximab in active ulcerative colitis

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Nov 2014

At a glance

  • Drugs Rituximab (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Apr 2011 Results published in the Gut.
    • 01 May 2010 Results presented at 2010 Digestive Disease Week.
    • 01 May 2010 Status changed from recruiting to completed, due to presentation of results at 2010 Digestive Disease Week.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top